Astrocytes or astroglia, the largest glial cell population in the central nervous system (CNS), perform numerous vital functions. Among other things, these glial cells (i.e., cells supporting functions of the nervous system) ...
Scientists have identified a single molecule that may explain how bacteria can trigger one of the most severe types of asthma, a discovery that for the first time identifies the "missing link" between exposure to bacterial ...
A naturally occurring antibody capable of stimulating the body's immune-suppressing regulatory T cells has been discovered by a team of Harvard scientists, a finding that may eventually open a new door into kinder, gentler ...
The immune system mounts robust responses to infections, vaccines and cancer, but only now have scientists fully begun to unravel how non-circulating populations of T cells that reside in the body's "mucosal barrier tissues" ...
(Medical Xpress) -- One of the many potential consequences of ischemic stroke – a lesion, or localized pathological change in the brain, in which blood flow insufficient to meet metabolic demand leads to poor oxygen ...
The Hass Avocado Board teamed up with the University of Eastern Finland researchers to examine the relationship between maternal avocado consumption during pregnancy and allergic outcomes in infants. Findings suggest that ...
Chronic rhinosinusitis with nasal polyps presents a substantial clinical burden, affecting nasal airflow, olfactory function, and quality of life. Epithelial barrier dysfunction and type 2 inflammatory responses drive disease ...
An international collaboration of researchers, sponsored by GSK and working on behalf of the ANCHOR-1 and ANCHOR-2 trial investigators, conducted two Phase III clinical trials to evaluate depemokimab, an ultra-long-acting ...
Northwestern University researchers have tested a method to reduce the dreaded nocturnal itch-scratch cycle. Using an AI-trained wearable sensor with vibrating feedback, the device significantly reduced nocturnal scratching ...
Results of a Phase III study conducted by an international team of researchers reveal that mirikizumab is more effective and has a favorable safety profile with fewer serious adverse events compared to a placebo for individuals ...
